(5-Trifluoromethyl)-4H-1,2,4-triazol-3-amine, 95.0%, 5g

1-Acetyl-4-bromo-5(3)-phenyl-3(5)-(trifluoromethyl)pyrazole, 95.0%, 5g

(2E)-3-(4'-Hydroxy-3'-tricyclo[3.3.1.13,7]dec-1-yl[1,1'-biphenyl]-4-yl)-2-propenoic acid, 98%, 5mg

Potassium sec-butylxanthogenate, 97%, 10g

5,6-Dichloro-1-ethyl-1H-benzo[d]imidazol-2(3H)-one, 95.0%, 25mg

TERT-BUTYL (2S)-2-(AMINOMETHYL)-2-ETHYLPYRROLIDINE-1-CARBOXYLATE, 95.0%, 1g

5-(2,5-dichloro-3-thienyl)-1,3,4-oxadiazol-2-amine, 95.0%, 250mg

5-BROMO-3-(1-BENZYL-1,2,3,6-TETRAHYDROPYRIDIN-4-YL)-1H-INDOLE, 97.0%, 250mg

TRANS-3-ETHOXYCYCLOBUTAN-1-AMINE HCL, 95.0%, 5g

6-Methyl-3H-pyrimidin-4-one, 95.0%, 1g

3-Iodo-1-methyl-1H-pyrazole-4-carboxylic acid, 97.0%, 250mg

Granulés d'étain 99,9997% 3 mm 100 g

diméthylsulfoxyde, min 99,5%, pour la synthèse, 2,5 l, emballage en verre